The MediChew® technology platform

Expert Opinion on Drug Delivery

Volumn 2, Issue 5, 2005, Pages 927-933

  Hyrup, Birgitte ^a   Andersen, Carsten ^a   Andreasen, Lars Vibe ^a   Tandrup, Bo ^a   Christensen, Torben ^a  

^a Fertin Pharma AS   (Denmark)

Author keywords

Controlled release; Drug delivery; Medical chewing gum; Medicated chewing gum; MediChew ; Modified release

Indexed keywords

ACETYLSALICYLIC ACID; CAFFEINE; CHLORHEXIDINE; DIMENHYDRINATE; ELASTOMER; FLUORIDE; LIDOFENIN TC 99M; METHADONE; MICONAZOLE; NICOTINE; NICOTINE GUM; PLASTICIZER; VERAPAMIL; DRUG; EXCIPIENT;

ARTICLE; CHEWING GUM; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG DOSE REGIMEN; DRUG INDUSTRY; DRUG METABOLISM; DRUG RELEASE; HUMAN; HYDROPHILICITY; IN VITRO STUDY; LOZENGE; MOTION SICKNESS; MOUTH CAVITY; MOUTH HYGIENE; MOUTH MUCOSA; PAIN; PATENT; SIDE EFFECT; SMOKING CESSATION; TASTE PREFERENCE; THROAT; REVIEW;

CHEWING GUM; DRUG DELIVERY SYSTEMS; EXCIPIENTS; HUMANS; PHARMACEUTICAL PREPARATIONS;

EID: 27144515651     PISSN: 17425247     EISSN: None     Source Type: Journal    
DOI: 10.1517/17425247.2.5.927     Document Type: Article

References (33)

1. FERTIN PHARMA A/S: Internal report. (2002).
2. RASSING MR: Specialised oral mucosal drug delivery dystems: chewing gum. In: Oral Mucosal Drug Delivery. MJ Rathbone (Ed.), Marcel Dekker, Inc., NY, USA (1996) 331.
3. KATSURAGI Y, KURIHARA K: Specific inhibitor for bitter taste. In: Modifying Bitterness. G Roy (Ed.), Technonomic Publishing company, Inc., Lancaster, PA, USA (1997) 255-281.
4. Dissolution test for medicated chewing gums. In: European Pharmacopeia. 5(2.9.25).
5. FERNÖ OVE: A substitute for tobacco smoking. Psychopharmacologica (1973) 31:201-204.
6. RASSING MR: Chewing gum as a drug delivery system. Adv. Drug Delivery Rev. (1994) 13:89-121.
7. 99mTcE-HIDA, in the oral cavity after administration of lozenges, chewing gum and sublingual tablets. Int. J. Pharmaceutics (1990) 66:169-174.
8. BENOWITZ NL, JACOB P 3rd, SAVANAPRIDI C: Determinants of nicotine intake while chewing nicotine polacrilex gum. Clin. Pharmacol. Ther. (1987) 41:467-473.
9. SILAGY C, LANCASTER T, STEAD L, MANT D, FOWLER G: Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev. (2002) (4):CD000146.
10. BOUSQUET E, TIRENDI S, BONINA FP, MONTENEGRO L, BIANCHI A, CIAMPINI N: Bioavailability of two formulations of acetylsalicylic acid gums. Pharmazie (1992) 47(H.8):607-609.
11. WOODFORD DW, LESKO LJ: Relative bioavailability of aspirin gum. J. Pharm. Sciences (1981) 70(12):1341-1343.
12. SKOFITSCH G, LEMBECK F: Serum levels of dimenhydrinate. Determination by HPLC with UV detection after intake of dimenhydrinate in a coated chewing gum dragee. Arzneimittelforschung (1983) 33(12):1674-1676.
13. KAMIMORI GH, KARYEKAR CS, OTTERSTETTER R et al.: The rate of absorption and relative bioavailability of caffeine administered in chewing gum versus capsules to normal healthy volunteers. Int. J. Pharmaceutics (2002) 234:159-167.
14. JESSEN AB, TOUBRO S, ASTRUP A: Effect of chewing gum containing nicotine and caffeine on energy expenditure and substrate utilization in men. Am. J. Clin. Nutr. (2003) 77:1442-1447.
15. ANKERSEN L, JESSEN A. TOUBRO S, ASTRUP A: The effect of a nicotine and caffeine chewing gum on appetite in lean non smoking males. Int. J. Obesity (2002) 26:158.
16. CHRISTRUP LL, BONDE J, RASMUSSEN SN, RASSING MR: Relative bioavailability of (±)-verapamil hydrochloride administered in tablets and chewing gum. Acta Pharm. Nord. (1990) 2(6):371-376.
17. CHRISTRUP LL, ANGELO HR, BONDE J, KRISTENSEN F, RASMUSSEN SN: Relative bioavailability of methadone hydrochloride administered in chewing gum and tablets. Acta Pharm. Nord. (1990) 2(2):83-88.
18. PEDERSEN M, RASSING MR: Miconazole chewing gum as a drug delivery system. Test of release promoting additives. Drug Dev. Industrial Pharmacy (1991) 17(3):411-420.
19. RINDUM JL, HOLMSTRUP P, PEDERSEN M, RASSING MR, STOLTZE K: Miconazole chewing gum for treatment of chronic oral candidosis. Scand. J. Dent. Res. (1993) 101:386-390.
20. BASTIAN HL, RINDUM J, LINDEBERG H: A double-dummy, double-blind, placebo-controlled Phase III study comparing the efficacy and efficiency of miconazole chewing gum with a known drug (Brentan® gel) and a placebo in patients with oral candidosis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. (2004) 98(4):423-428.
21. SJÖGREN K, BIRKHED D, PERSSON LG, NORÉN JG: Salivary fluoride clearance after a single intake of fluoride tablets and chewing gums in children, adults, and dry mouth patients. Scand. J. Dent. Res. (1993) 101:274-278.
22. SJÖGREN K, LINGSTRÖM P, LUNDBERG A-B, BIRKHED D: Salivary fluoride concentration and plaque PH after using a fluoride-containing chewing gum. Caries Res. (1997) 31:366-372.
23. SJÖGREN K, LINGSTRÖM P, RUBEN J, BIRKHED D: Fluoride chewing gum in an intraoral caries model. J. Dent. Res. (1999) 78:202.
24. LAMB WJ, CORPRON RE, MORE FG, BELTRAN ED, STRACHAN DS, KOWALSKI CJ: In situ remineralization of subsurface enamel lesion after the use of a fluoride chewing gum. Caries Res. (1993) 27:111-116.
25. AINAMO J, NIEMINEN A, WESTERLUND U: Optimal dosage of chlorhexidine acetate in chewing gum. J. Clin. Periodontol. (1990) 17:729-733.
26. SMITH AJ, MORAN J, DANGLER LV, LEIGHT RS, ADDY M: The efficacy of an anti-gingivitis chewing gum. J. Clin. Periodontol. (1996) 23:19-23.
27. SIMONS D, KIDD EAM, BEIGHTON D, JONES B: The effect of chlorhexidine/xylitol chewing-gum on cariogenic salivary microflora: a clinical trial in elderly patients. Caries Res. (1997) 31:91-96.
28. SIMONS D, BEIGHTON D, KIDD EAM, COLLIER FI: The effect of xylitol and chlorhexidine acetate/xylitol chewing gums on plaque accumulation and gingival inflammation. J. Clin. Periodontol. (1999) 26:388-391.
29. SIMONS D, BAKER P, KNOTT D, RUSH S, BRIGGS T, KIDD EA, BEIGHTON D: Attitudes of carers and the elderly occupants of residential homes to antimicrobial chewing gum as an aid to oral health. Br. Dent. J. (1999) 187(11):612-615.
30. SIMONS D, BRAILSFORD S, KIDD EA, BEIGHTON D: The effect of chlorhexidine acetate/xylitol chewing gum on the plaque and gingival indices of elderly occupants in residential homes. J. Clin. Peridontol. (2001) 28:1010-1015.
31. SIMONS D, BRAILSFORD SR, KIDD EA, BEIGHTON D: The effect of medicated chewing gums on oral health in frail older people: a 1-year clinical trial. J. Am. Geriatr. Soc. (2002) 50:1348-1353.
32. SCHÖNFELD JV, HECTOR M, EVANS DF, WINGATE DL: Oesophageal acid and salivary secretion: is chewing gum a treatment option for gastro-oesophageal reflux? Digestion (1997) 58:111-114.
33. AVIDAN B, SONNENBERG A, SCHNELL TG, SONTAG SJ: Walking and chewing reduce postprandial acid reflux. Aliment. Pharmacol. Ther. (2001) 15:151-155.